FDA Inspection 1158649 — Ira H. Thorla, Jr., MD

Ira H. Thorla, Jr., MD — FEI 3010700997

The FDA completed an inspection of Ira H. Thorla, Jr., MD on Nov 18, 2021 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 18, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Baton Rouge, LA (United States)

Additional Details

Clinical Investigator (CI)